Introduction
Screening for genes that control developmental timing in the nematode Caenorhabditis elegans led to the discovery of the first microRNA (miRNA) gene, lin-4, and its target lin-14 in 1993 (Lee et al., 1993; Wightman et al., 1993) . The authors proposed that the 22-nucleotide-long lin-4 non-coding RNA negatively regulates translation of its target lin-14 mRNA by binding to complementary sites within the 3 0 -untranslated region (UTR) via imperfect base pairing. Although the community considered those publications a beautiful and interesting set of work, most regarded it as a worm-specific oddity. In the year 2000, Ruvkun and co-workers could show that another regulator of developmental timing in C. elegans -let-7 -also encoded a small non-coding RNA . To everyone's surprise, the sequence as well as expression pattern of let-7 were conserved from worms to mammals . The importance of this new class of molecules was fully appreciated when many more such small RNAs were identified in worms, flies, mammals and flowering plants by cloning and bioinformatics prediction strategies (Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 2001; Llave et al., 2002; Reinhart et al., 2002) . These small RNAs, termed miRNAs (reviewed by Ambros, 2004; Bartel, 2004) , have since been implicated in a large number of biological processes including developmental timing, cell fate determination, cell death and cancer (reviewed by Alvarez-Garcia and Miska, 2005) . miRNA biogenesis and function miRNA processing has been the focus of several review articles (Kim, 2005; Zeng, 2006, this issue) and therefore we will only briefly mention the most important steps. miRNAs are encoded in the genome and are transcribed by RNA polymerase II (pol II) as long precursor transcripts, which are known as primary miRNAs (pri-miRNAs). The pri-miRNAs are capped and polyadenylated like other pol II transcripts, and can be up to several kilobases long (for review, see Cullen, 2004; Kim, 2005) . A great number of miRNAs are found within introns of known protein-coding genes. Another third of all pri-miRNAs seem to lack open reading frames, suggesting that the main function of these transcripts is the production of miRNAs. Neverthelessand quite surprisingly -these transcripts are often spliced and the miRNAs are frequently located within their intronic segments (Rodriguez et al., 2004) . One primiRNA can contain only one, or up to several miRNAs. Within the pri-miRNA, the miRNA itself is contained within an approximately 60-80 nucleotide sequence that has the ability to fold back on itself in order to form a stem-loop hairpin structure via imperfect base pairing.
Mature miRNAs are generated from pri-miRNAs by sequential processing steps. The pri-miRNAs are initially recognized by the microprocessor complex in the nucleus, whose core components are the RNase-III enzyme Drosha and its partner DGCR8/Pasha (Denli et al., 2004; Gregory et al., 2004; Han et al., 2004; Landthaler et al., 2004) . The microprocessor complex excises the stem-loop hairpin structure that contains the miRNA, a 60-80 nucleotide intermediate termed precursor miRNA (pre-miRNA). The pre-miRNA is recognized by the nuclear export factor Exportin-5, which transports it to the cytoplasm Bohnsack et al., 2004; Lund et al., 2004) . There, a second RNase-III enzyme named Dicer performs a second cleavage to generate double-stranded 18-24 nucleotide-long RNA molecules -miRNAs Grishok et al., 2001; Hutvagner et al., 2001; Ketting et al., 2001; Knight and Bass, 2001) . One of these two strands -the guide strand -is then incorporated into the large protein complex known as RNA-induced silencing complex (RISC), the core component of which is the Argonaute protein (Kim, 2005) .
The miRNA guides the RISC complex to the target mRNA, which will then be subsequently cleaved or translationally silenced, depending on the degree of sequence complementarity of the miRNA to its target mRNA (Hutvagner and Zamore, 2002; Doench et al., 2003; Zeng et al., 2003) . Currently, it is believed that perfect or nearly perfect complementarity leads to mRNA degradation; this is the situation most commonly observed in plants. In contrast, imperfect base pairing, as is primarily found in animals, leads to translational silencing. However, recent data suggest additional complexity: miRNAs in animals have been found to lead to considerable cleavage of target mRNAs (Bagga et al., 2005; Lim et al., 2005) . For more detailed information on miRNA mode of action, we refer the reader to the recent reviews that cover this complex topic (Engels and Hutvagner, 2006, this issue; ValenciaSanchez et al., 2006) . We will focus our discussion on the involvement of miRNAs in apoptotic processes.
Time for take off -it all started with Drosophila melanogaster
In Drosophila, several pathways are known to control caspase activity (Hay, 2000; Tittel and Steller, 2000; Salvesen and Abrams, 2004; Kornbluth and White, 2005) . All pathways seem to depend on the inhibitor of apoptosis proteins (IAP), as loss of DIAP1 results in rapid apoptosis in virtually all cells in Drosophila (Goyal et al., 2000; Lisi et al., 2000; Yoo et al., 2002) . DIAP1 acts as a central brake on apoptosis, inhibiting activated caspases (Hay, 2000) . Caspase binding to DIAP1 can result in sequestration of the caspase away from its targets and/or in caspase degradation. The IAP-binding motif proteins Reaper (Rpr), Grim (Grm), Head Involution Defective (Hid) and Sickle (Skl) compete with caspases for binding to DIAP1 and therefore promote apoptosis. Rpr and Grm can also suppress DIAP1 translation (Holley et al., 2002; Yoo et al., 2002) . This is the main mechanism of apoptosis induction in fly development, as well as in response to stresses such as DNA damage (White et al., 1994; Nordstrom et al., 1996; Brodsky et al., 2004) . All important components of the Drosophila cell death machinery and sites of proposed miRNA action discussed in this review are summarized in Figure 1 . miR-14: a dose-dependent suppressor of cell death and regulator of fat storage The involvement of miRNAs in cell death regulation was first reported 3 years ago when the first two miRNAs, miR-14 and bantam, were shown to regulate apoptosis in Drosophila. Xu et al. (2003) identified miR-14 in a screen for new inhibitors of apoptotic cell death. They tested existing collections of P element insertion lines for their ability to enhance a small-eye phenotype associated with the eye-specific expression of the Drosophila cell death activator Reaper. One of the enhancers that were identified was the miRNA miR-14. The effect of miR-14 on apoptosis is highly dosage sensitive. Flies heterozygous for a miR-14 loss-of-function mutation (50% reduction) showed an enhancement of the small-eye phenotype. Conversely, overexpression of a fragment containing the miR-14 gene could suppress the small-eye phenotype in a dosedependent manner. In addition, eye-specific expression of miR-14 could also suppress the small-eye phenotype caused by the expression of Grim and Hid. Even the late-onset retinal cell death caused by expression of the initiator caspase Dronc could be suppressed by miR-14. Nonetheless, not all apoptosis-related molecules could be suppressed by miR-14 expression; apoptosis induced by the expression of the long prodomain caspase Strica and the Ras pathway negative regulator Tramtrack could not be suppressed by miR-14. Taken together, these data indicate that miR-14 is a dose-dependent suppressor of Rpr-, Hid-, Grim-and Dronc-dependent cell death (Xu et al., 2003) .
In order to identify possible targets of miR-14, a bioinformatics search was conducted for potential binding sites of miR-14 in the 3 0 UTRs of all genes. One interesting candidate found was the effector caspase Drice. Drice is activated by Dronc, which is in turn activated by Hid, Rpr, Grm and Skl (Figure 1 ). Therefore, Drice being a direct target of miR-14 would nicely correlate with the data the authors had accumulated so far. Western blot analysis confirmed that Drice is considerably upregulated in a miR-14 mutant background and that this upregulation was suppressed upon ectopic expression of miR-14. This strongly suggests that miR-14 controls the expression of Drice either directly or indirectly (Figure 1 ).
bantam -a regulator of cell proliferation and of cell death bantam was first identified in a gain-of-function screen for genetic elements that affect tissue growth. Several EP element insertions within a region that lacked any predicted protein-coding sequences caused overgrowth of wing and eye tissue (Hipfner et al., 2002) . EP elements are transposable elements that allow inducible overexpression of sequences flanking the insertion site (Rorth, 1996) . Furthermore, it was deduced that the increase in tissue size is due to an increase in cell number and not cell size. bantam, the gene causing this overgrowth phenotype, turned out to encode a miRNA . Via Northern blot analysis, the authors could deduce that bantam is expressed at all developmental stages, although at varying levels. In order to get a more detailed picture, the authors pioneered the use of in vivo sensors to follow a miRNA's expression pattern. Based on the ability of miRNAs to promote an RNAi-like degradation of mRNAs to which they base pair perfectly (Hutvagner and Zamore, 2002; Martinez et al., 2002; Zeng et al., 2002) , they constructed a transgene-expressing green fluorescent protein (GFP) under the strong ubiquitous tubulin promoter. Downstream of the GFP-coding region, they introduced a 3 0 UTR containing two perfect copies of the bantam target sequence. As a control, they used the same construct but without the two target sequences in its 3 0 UTR. Where present, bantam should reduce the expression of the GFP sensor by RNAi. The sensor was very sensitive to changes of the miRNA levels and allowed a detailed spatial reconstruction of bantam expression. By simultaneously monitoring the GFP sensor and bromodeoxyuridine incorporation, the authors could show that bantam expression is generally Figure 1 Regulation of the apoptotic machinery by miRNAs in Drosophila melanogaster. DIAP1 is the main regulator of cell death in Drosophila. Absence of DIAP1 results in rapid apoptosis in nearly all cells of Drosophila. Dark, the Drosophila apoptotic-proteaseactivating factor-1 (Apaf-1) seems to be constitutively active, and it is unclear whether the level of its activity is controlled. Active Dark results in the activation of the initiator caspase Dronc, which in turn results in the activation of the effector caspase Drice. Lack of regulation in the activation of Drice results in apoptosis. However, the activation and/or activity of Dronc and Drice are normally antagonized by DIAP1. DIAP1 itself can be regulated via several pathways, but regulation via Hid, Reaper, Grim and Sickle seems to be the most prominent one. Hid, Reaper, Grim and Sickle are so-called IBM proteins (IAP-binding motif) that prevent DIAP1 function via direct interaction. Therefore, IBM protein induction results in rapid cell death. IBM protein induction is tightly regulated at the transcriptional and post-transcriptional levels. miRNAs appear to contribute substantially to post-transcriptional regulation of that family. Experimentally verified miRNAs involved in the regulation include bantam and the miR-2 family. A more detailed picture of the regulation of IBM proteins by the miR-2 family is given in the small table (adapted from Leaman et al., 2005) . Bantam not only prevents apoptosis, but also positively regulates cell proliferation. miR-14, another miRNA with antiapoptotic activity, has been proposed to regulate Drice expression. However, more experimental evidence is needed to support the data obtained so far, which is here indicated by the question mark. miR-278 has been proposed to antagonize apoptosis through its regulation of expanded. Expanded and Merlin can transduce a signal that facilitates phosphorylation and therefore activation of the Warts/Mats complex by Hippo, which itself is in a complex with Salvador. Activation of Warts/Mats results in phosphorylation and inactivation of Yorkie and therefore in inhibition of diap1 and cyclin E transcription. Furthermore, Warts/Mats can directly inhibit DIAP1 protein function by phosphorylation, which favors apoptosis. Proapoptotic proteins are depicted in red and prolife proteins in green. miRNAs are colored in blue; all of them seem to have prolife activity. Proteins surrounded by a box work together in a complex. Proteins surrounded by a dashed line have similar and partly overlapping functions. miRNAs and apoptosis M Jovanovic and MO Hengartner higher in proliferating cells. This effect appears to be causal: clones having two wild-type copies of bantam were on average threefold bigger in size when compared to homozygous mutant clones. Thus, bantam can cellautonomously promote cell proliferation.
Overexpression of the oncogenes Myc or E2F in mammalian cells induces simultaneously both proliferation and apoptosis (Evan et al., 1994; Dyson, 1998; Harbour and Dean, 2000; Pelengaris et al., 2002) . Interestingly, the same is true in Drosophila: overexpression of E2F and its cofactor DP causes apoptosis in the wing imaginal disc; this death can be blocked by coexpression of the caspase inhibitor p35 (Neufeld et al., 1998) . In contrast, stimulation of proliferation by bantam was not accompanied by apoptosis. Moreover, expression of bantam could significantly reduce E2F-and DP-induced apoptosis, resulting in even stronger tissue overgrowth. Taken together, these results indicate that bantam simultaneously inhibits apoptosis and promotes cell proliferation.
In order to identify targets of the bantam miRNA, the authors conducted a bioinformatics search for 3 0 UTRs with potential bantam-binding sites. They identified the proapoptotic factor hid as a possible target owing to its biological function and the presence of five potential bantam-binding sites in its 3 0 UTR. Fusion of the hid 3 0 UTR to the tubulin GFP sensor (GFP-hid) resulted in an expression pattern identical to the one that the authors had observed previously with the 3 0 UTR containing two perfect bantam target sites, indicating that the hid 3 0 UTR is also targeted for regulation by bantam. Overexpression of bantam led to an even stronger downregulation of the GFP-hid sensor, whereas mutation of two of the five potential target sites significantly reduced sensitivity to bantam expression. Whether the five predicted bantam sites function additively or cooperatively remains to be determined.
Having shown that bantam is able to regulate transgene expression via the hid 3 0 UTR, the authors tested whether this was also the case for the endogenous hid gene. Coexpression of bantam and hid resulted in reduced Hid protein levels. However, hid transcript levels stayed stable, suggesting that the expression of Hid protein is controlled post-transcriptionally by the bantam miRNA -probably through inhibition of translation, the preferred mode of action of animal miRNAs. Finally, in order to prove a functional relationship between hid and bantam, the authors showed that Hid-induced apoptosis, which can be clearly visualized by caspase-3 activation, could be suppressed by bantam coexpression.
In summary, the Cohen laboratory (Hipfner et al., 2002; Brennecke et al., 2003) identified by a conventional gain of function screen a miRNA gene that positively regulates cell proliferation and suppresses apoptosis -two features typical of oncogenes (Figure 1 ). In addition this work was the first to apply a GFP sensor in vivo to follow miRNA expression patterns and also successfully used a bioinformatics approach to identify a biologically relevant target of the bantam gene. However, regulation of hid only explains the antiapoptotic effect of bantam: loss of hid function results in reduced apoptosis in vivo but does not cause excessive proliferation. Therefore, the direct targets of bantam that influence cell proliferation still need to be identified.
yand it keeps flying -further discoveries in D. melanogaster
The miR-2 family regulates cell survival via the proapoptotic factors Hid, Grim, Reaper and Sickle Injection of 2 0 O-methyl antisense oligoribonucleotides (2 0 OM-ORNs) complementary to miRNAs into cells or into early Drosophila embryos leads to specific and efficient depletion of the targeted miRNAs, probably by stoichiometrically binding to RISCs containing the cognate miRNA and thus preventing interaction with mRNA targets (Hutvagner et al., 2004; Meister et al., 2004) . Leaman et al. (2005) used this approach to perform a systematic analysis of miRNA functions during Drosophila embryonic development. The authors tested all 46 miRNAs that are expressed during the first half of embryogenesis in Drosophila. Inactivation of 25 of the 46 miRNAs (54%) resulted in a visible defect. Inactivation of individual members of the two large miRNA families that exist in Drosophila (the miR-310 family, which consists of miR-310/311/312/313/92, and the miR-2 family, which includes miR-2/6/11/13/308) resulted in similar but distinct phenotypes, indicating that family members likely regulate overlapping but distinct sets of targets. Interestingly, 87% of the miRNAs belonging to larger families showed a phenotype, whereas only 39% of the tested single copy miRNAs did so. It is possible that single-copy miRNAs have more restricted expression profiles and that their inactivation leads to rather subtle defects, which might have escaped detection in a large-scale loss-offunction screen. Another interesting observation of this systematic analysis is that most of the detected defects were quite specific, suggesting that miRNAs have either a relatively small number of phenocritical targets, or multiple targets that participate in the same biological function.
The phenotypes observed in this study ranged from cellularization defects (e.g. miR-9) via segmentation defects (e.g. miR-31) to dorsal closure defects (miR-310 family). Interestingly, depletion of some members of the miR-2 family resulted in catastrophic apoptosis, which prompted the authors to investigate that family further.
Embryos injected with 2 0 OM-ORNs for miR-6 and miR-2/13 (miR-2 and miR-13 are nearly identical, differing by only two bases, and cannot be inhibited individually) failed to differentiate normal internal and external structures and fell apart on touch at the end of embryogenesis. One possible cause for these phenotypes could be excessive and widespread apoptosis. Anti-caspase-3 (CM1) staining confirmed that notion: apoptosis was greatly increased in miR-2/13-and miR-6-depleted embryos when compared to control embryos. The miR-6 phenotype was generally stronger, suggesting miRNAs and apoptosis M Jovanovic and MO Hengartner greater excess or an earlier onset of apoptosis. Interestingly, overexpression of the cognate miRNA together with injection of the antisense 2 0 OM-ORN could partially rescue the observed phenotype. Depletion of the other two miR-2 family members, miR-11 and miR-308, resulted in only moderate or mild increases in cell death, respectively. Therefore, individual depletion of all miR-2 family members results in excess cell death but with a marked difference in phenotypic strength. One possible explanation for the phenotypic differences is that the miRNA family members' expression levels differ significantly: Northern blot analysis confirmed that this was indeed the case. An additional reason is probably also the slightly different specificity of miRNA family members.
Injection of miR-2/13 and miR-6 antisense 2 0 OMORNs into embryos mutant for the hid, grim and reaper genes was unable to trigger apoptosis, suggesting that these miRNAs act, directly or indirectly, through hid, reaper and/or grim. To test this hypothesis, the authors determined expression levels of these proapoptotic genes in embryos depleted of miR-2/13 or miR-6. Although there were no significant changes in mRNA expression levels, Hid protein levels were dramatically higher in miR-6-depleted embryos and modestly increased in miR-2/13-depleted embryos. This argues in favor of a post-transcriptional regulation of the proapoptotic factor Hid by miR-2/13 and miR-6. In order to test the influence of the 3 0 UTR on the expression of Reaper, Grim, Hid and Sickle proteins in greater detail, the authors made use of the GFP sensor assay described above. These studies revealed that each miRNA has a distinct interaction profile with the four proapoptotic factors (see small table within Figure 1) . Hid is controlled solely by miR-6, Reaper is under strong control by miR-2/13 and miR-6 and under modest control by miR-11, Grim expression is affected by miR-2/13, miR-11 and miR-308, and Sickle is controlled by all members of the miR-2 family. These distinct interaction profiles correlate well with the observed phenotypes: miR-6-depleted embryos, for example, show the strongest phenotype of all miR-2 family members, which is readily explained by its strong interaction with hid, which has the broadest expression and the strongest proapoptotic effect.
Interestingly, already earlier computational searches for miR-2 family member binding sites indicated that reaper and grim have one binding site, whereas hid and sickle have two predicted binding sites each (Enright et al., 2003; Stark et al., 2003) . Moreover, by fusing the corresponding 3 0 UTR to the tubulin-GFP sensor, Stark et al. (2003) could show that overexpression of miR-2 did indeed lead to downregulation of the GFP signal under the control of either the reaper, grim or sickle 3 0 UTR. Interestingly, post-transcriptional control of hid during embryonic development had already been proposed in the mid1990s owing to the divergence between the patterns of embryonic cell death and of hid transcript expression (White et al., 1994; Grether et al., 1995; Chen et al., 1996) . Some of those earlier observations might be readily explained by the data presented in the publication described above (Leaman et al., 2005) . miR-278 -controlling death via the gene expanded? miR-278 was identified in a gain-of-function screen for eye overgrowth (Nairz et al., 2006) . miR-278 is highly expressed in all three larval stages, in pupae and in adult flies and appears to be a fly-specific miRNA. As the overexpression of this miRNA causes significant overgrowth, Nairz et al. (2006) tried to isolate mutant alleles of miR-278 by mutagenizing a fly strain overexpressing miR-278 and looking for suppressors of the overgrowth phenotype. One potential suppressor was found to contain a point mutation (U to A) at position 5 of the mature miRNA. As this mutation lies within the so-called seed region, which is thought to be crucial for target recognition (Lee et al., 1993; Wightman et al., 1993; Lai, 2002; Enright et al., 2003; Lewis et al., 2003; Stark et al., 2003; Doench and Sharp, 2004; Brennecke et al., 2005) , the authors argued that this mutation should compromise the function of miR-278 considerably. Indeed, overexpression of this mutant miR-278 did not result in tissue overgrowth in the eye. However, the overexpression of the mutant miR-278 still caused a slightly rough appearance of the compound eye, indicating that it is not a complete null mutation and still harbors some residual activity.
The miR-278 overexpression phenotype resembles the one caused by loss-of-function mutations in the tumor suppressor gene warts/lats: in both cases, overgrowth in the eye is mainly caused by supernumerary cells of normal size. The extra cells in warts/lats mutants originate from the intervening space between the ommatidia (Justice et al., 1995) . In normal eye development, these extraneous cells are eliminated via apoptosis (Wolff and Ready, 1993) . To test whether overexpression of miR-278 might also interfere with apoptosis in the developing eye, the authors assessed the miRNA's ability to suppress the small, rough eye phenotype caused by overexpression of various proapoptotic factors. Indeed, overexpression of miR-278 could suppress the small, rough eye phenotype caused by eye-specific expression of hid or grim, as had been previously shown for bantam, miR-14 and the miR-2 family (see above and Brennecke et al., 2003; Xu et al., 2003; Leaman et al., 2005) . However, in contrast to those miRNAs, loss of miR-278 function could not enhance the small, rough eye phenotype. Generally, the authors failed to detect any obvious phenotype in the homozygous mutant flies. This could be due to the fact that the mutant they isolated is probably not a null mutant. Owing to the lack of a phenotype of the homozygous miR-278 mutant, the authors were cautious in their interpretation of the phenotype caused by overexpression of miR-278, even speculating that the overexpression could be some neomorphic function.
An independent analysis of miR-278 was reported by the Cohen laboratory (Teleman et al., 2006) , which likewise identified miR-278 in a gain-of-function screen for genes that cause tissue overgrowth (in their case, in the posterior compartment of the wing). In this case, the authors managed to generate null mutants by homologous recombination, and observed that homozygous null mutant animals were viable and normal in size.
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On closer inspection a 'lean' phenotype was observed, meaning that mutant flies had reduced levels of triacylglycerides. After checking several markers that could cause such a phenotype, they found that insulinlike peptides (ILPs) were upregulated in the brain, resulting in a constitutive activation of insulin signaling pathways. By reducing the insulin signaling capacity, the authors could suppress the leanness of the miR-278 mutants. Interestingly, although the ILPs were upregulated in the miR-278 mutants, the same animals also had elevated circulating sugar levels, which likely explain the elevated insulin production. The authors could in the end pinpoint the defect to the fat body, which they found to be specifically insulin resistant -a condition known to cause leanness in Drosophila (Teleman et al., 2005) .
So how is the lean phenotype connected to the antiapoptotic effect of miR-278 overexpression observed by Nairz et al. (2006) ? The Cohen group was able to identify a possible miR-278 target, which might actually explain both the insulin-resistant phenotype of the miR-278 loss-of-function mutant and the antiapoptotic effect caused by overexpression of the same miRNA. Through a bioinformatics approach, comparative microarray analysis of the mutant to wild type and subsequent reporter assays, the authors were able to establish the gene expanded as a likely target candidate. Indeed, overexpression of Expanded in the eye, which causes a small, rough eye phenotype, was significantly suppressed by simultaneous overexpression of miR-278. miR-278 overexpression was also able to reduce the expression of the endogenous Expanded protein in the wing imaginal disc, as well as Expanded overexpressed from a UAS transgene thus confirming that the regulation is posttranscriptional. Last but not least, coexpression of Expanded from a transgene suppressed the overgrowth caused by miR-278 overexpression. Do these observations explain the antiapoptotic effects of miR-278? They just might, if one considers recent findings suggesting that expanded and nf2/merlin act through a recently discovered tumor suppressor pathway that coordinately regulates cell proliferation and apoptosis (Edgar, 2006; Hamaratoglu et al., 2006) . This pathway is composed of the serine/ threonine kinases Hippo and Warts, the adaptor molecule Salvador, Mats (Mob as tumour suppressor, a regulator of Warts) and Yorkie, a transcriptional coactivator that promotes expression of growth and survival factors such as cyclin E and DIAP1. Activation of the pathway leads to inhibition of Yorkie, thereby suppressing cell proliferation and promoting programmed cell death (Figure 1 ; reviewed by Edgar, 2006) . By negatively regulating expanded expression, miR-278 can thus act as an antiapoptotic factor, which nicely explains the phenotypes observed by Nairz et al. (2006) .
Time to land -miRNAs connected to apoptosis in mammals
An exciting development in the miRNA field has been the rapidly accumulating evidence that deregulation of miRNAs might contribute to many types of diseases, including cancer (Alvarez-Garcia and Mendell, 2005; Esquela-Kerscher and Slack, 2006; Hammond, 2006; Hwang and Mendell, 2006; Mendell, 2006 this issue; Slack and Weidhaas, 2006) .
About half of the known human miRNA genes are located in cancer-associated regions, including common chromosomal breakpoints, regions of loss of heterozygosity (LOH), amplified regions, fragile sites and hotspots for papilloma virus integration sites (Calin et al., 2004) . Examples include malignant lymphomas that are often characterized by amplification of the miR-17 gene cluster (Ota et al., 2004; He et al., 2005) and miR-155, which is highly expressed in Burkitt and diffuse large B-cell lymphomas (Metzler et al., 2004; Eis et al., 2005) . Conversely, it has been shown that over 50% of all cases of the most common form of adult leukemia, chronic lymphocytic leukemia (CLL), carry a deletion at 13q14. Two miRNAs encoded in that region, miR-15 and miR-16, are downregulated or deleted in 68% of the CLL patients (Calin et al., 2002) . Likewise, the miR-99a/let-7c/ miR-125b2 cluster maps to a homozygous deletion found in lung cancers and the homologous cluster miR-100/let-7a/miR-125b to a loss-of-heterozygosity region linked to breast carcinomas (Calin et al., 2004) . Both C. elegans and human let-7 homologs have been reported to regulate Ras expression (Johnson et al., 2005) . Other data indicate that miR-143 and miR-145 levels are lowered in colorectal neoplasia (Michael et al., 2003) . In summary, alterations of miRNA expression levels (through over-, under-or misexpression) are tightly correlated with malignancies.
Another striking example was published by Lu et al. (2005) , who used a new bead-based flow cytometric miRNA expression profiling method to systematically analyse the expression of 217 mammalian miRNAs in 334 samples, including multiple human cancers. The resulting miRNA expression profiles were surprisingly informative, reflecting the developmental lineage and differentiation state of the tumors. Poorly differentiated tumors could be classified much more accurately using the expression profiles of the 217 miRNAs than with mRNA expression profiles of 16 000 genes. Interestingly, the authors observed a general downregulation of most miRNAs in tumors when compared to normal tissues. However, particular miRNAs were specifically upregulated depending on the tumor type. The authors speculated that global miRNA expression might reflect the state of cellular differentiation. Therefore, the general downregulation of miRNAs could indicate that those cancer cells regained a more 'stem-cell like character', and that the increased proliferative capacity associated with that status might contribute to their malignancy.
Because avoidance of apoptosis is an important property of malignant tumors, one way for miRNAs to influence cancer development might be by regulating apoptosis. Several lines of evidence suggest that this is indeed the case (Figure 2) .
A screen for miRNAs involved in cell growth and in apoptosis and the story about miR-21 Cheng et al. (2005) made use of an antisense RNA library to specifically knock down 90 human miRNAs in two different cell lines -HeLa (cervical carcinoma) and A549 (lung carcinoma) -and tested for changes in cell growth or apoptosis. In HeLa cells, inhibition of 19 miRNAs resulted in reduced proliferation, whereas inhibition of two miRNAs, miR-21 and miR-24, gave rise to greater cell proliferation. Surprisingly, inhibition of miR-24 in A549 cells resulted in the complete opposite phenotype: significant reduction of cell growth. This result suggests that the same miRNA might have completely different effects, depending on the cellular environment or context. The antiproliferative activity of miR-21 in HeLa cells is also intriguing, because miR-21 has been reported to act as an antiapoptotic factor in human glioblastoma cells (Chan et al., 2005 and below) ; therefore, one would have expected inhibition of miR-21 to result in a reduction of cell growth. Finally, inhibition of miR-21 in A549 cells did not result in either significant up-or downregulation of cell growth. Thus, similarly to miR-24, miR-21 might have different functions in different tissues. Cheng et al. (2005) also found that inhibition of seven miRNAs (miR-1d, 7, 148, 204, 210, 216 and 296) lead to increased caspase-3 activity and one miRNA (miR-214) lead to decreased activity. How the various miRNAs influence apoptosis remains to be determined. Nevertheless, these experiments show the potential of such global screens to identify interesting candidate miRNAs, which can then be studied further using more specific approaches.
As mentioned above, miR-21 can also function as an antiapoptotic factor. Glioblastoma, a highly malignant Figure 2 Regulation of the apoptotic machinery by miRNAs in mammals. The mitochondrial apoptosis pathway is activated by cytochrome c release from mitochondria, which leads to the formation of the mammalian Apaf-1 and pro-caspase-9-containing apoptosome, resulting in the activation of the initiator caspase-9. Caspase-9 activates effector caspases (e.g. caspase-3) that induce cell death. Cytochrome c release itself is controlled by the Bcl-2 family. BH3-only domain proteins (e.g. PUMA) inhibit prosurvival family members (e.g. BCL2), thereby preventing them from interacting with and inhibiting the proapoptotic family members (e.g. BAX), which in turn promotes cytochrome c release. BCL2 has been shown to be a likely target of the proapoptotic miRNAs, miR-15 and miR-16. As in Drosophila, caspases are also inhibited by IAP proteins; the most prominent example in mammals is XIAP. The IAP proteins can be targeted for degradation by proapoptotic factors, such as SMAC/Diablo, another protein released from mitochondria together with cytochrome c. The death receptor pathway is activated by binding of secreted ligands to cell surface receptors, which belong to the tumor necrosis factor-receptor family. Binding of the ligand to its cognate receptor (FAS Ligand to FAS are shown in the figure) results in receptor aggregation and subsequent recruitment of cytosolic proteins, such as Fas-associated death domain protein (FADD) and the pro-caspase-8 to the aggregated receptors, forming a death-inducing signaling complex (DISC). Within the DISC, procaspase-8 is cleaved into the active initiator caspase-8, which triggers the activation of effector caspases, such as caspase-3. Expression of the c-Myc oncogene stimulates in transcription of the pro-proliferative and proapoptotic factors E2F (E2F1-3), which are themselves positive regulators of c-Myc expression through a positive feedback loop. Up to a certain threshold, E2Fs are proposed to favor cell proliferation, but excessive expression of these factors results in apoptosis. The miR-17 cluster, which has prosurvival activity, has been shown to negatively regulate the expression of at least one E2F protein (E2F1) and might thereby prevent excessive accumulation of E2Fs and apoptosis. However, the miR-17 cluster might also block apoptosis via a different pathway; by negatively regulating PTEN, miR-17 cluster expression could result in upregulation of the PI3Kinase-Akt pathway -a pathway known to promote cell survival. Nevertheless, convincing experimental evidence is still missing and therefore in this figure, the possibility of the miR-17 cluster blocking apoptosis via this route is depicted as a dashed line with a question mark. miR-21 has been shown to be an antiapoptotic factor in certain environments, but it is not known how it might regulate apoptosis, as no experimental data are available on possible targets (symbolized by the question mark). Prosurvival factors are marked green and proapoptotic factors are colored red in the figure. Proteins that can function in either way are shown in black and miRNAs are depicted in blue.
miRNAs and apoptosis M Jovanovic and MO Hengartner human brain tumor, strongly overexpresses miR-21: Chan et al. (2005) reported greatly elevated levels of miR-21 in human glioblastoma tumor tissues, in early-passage glioblastoma cultures and in six established glioblastoma cell lines. Knock down of miR-21 in cultured glioblastoma cells resulted in a significant drop in cell number. This reduction was not due to large differences in proliferation, but rather due to an increase in apoptosis, as measured by caspase-3 and -7 enzymatic activity and TdT-mediated dUTP nick-end labeling (TUNEL) staining. How miR-21 antagonizes apoptosis, and whether it acts directly or indirectly still needs to be determined.
miR-15 and miR-16 induce apoptosis by targeting BCL2 As we already mentioned above, miR-15 and miR-16 are significantly downregulated or even lost in 68% of CLL patients (Calin et al., 2002) . What is the selection mechanism that drives cancer cells to loose miR15a/ miR-16-1 expression? Work by Cimmino et al. (2005) suggests that these two miRNAs antagonize tumor development by promoting apoptosis. The authors showed that miR-15a and miR-16-1 expression is indeed inversely correlated with Bcl2 expression in CLL cells. Moreover, the Bcl2 3 0 UTR region contains one potential binding site for both miRNAs. Ectopic expression of either miRNAs in cell lines with high BCL2 levels caused a dramatic reduction in BCL2 protein levels, without affecting Bcl2 mRNA levels indicating that the regulation of expression is post-transcriptional. In addition, the authors showed that the regulation of BCL2 levels by those two miRNAs depends on the potential binding site in the 3 0 UTR of Bcl2. Whether Bcl2 is the only, or even the major target of miR-15 and miR-16 during cancer development remains to be determined.
The Myc enigma
The miR-17 cluster, located on the human chromosome 13q31 and consisting of six miRNA (miR-17-5p, -18, -19a, -19b, -20 and -92) , is located in a region often amplified in lymphoma and other tumor types (Ota et al., 2004) . He et al. (2005) found that the levels of primary and mature miRNAs derived from the miR-17 cluster are often substantially upregulated in B-cell lymphoma. To test if upregulation of that cluster might be associated with tumor development, the authors used a mouse model of human B-cell lymphoma. In this mouse model, transgenic animals carrying a c-Myc oncogene, driven by the immunoglobulin heavy-chain enhancer (Em), develop B-cell lymphoma by 4-6 months of age. Infection of blood-forming cells from these mice with a retrovirus carrying a truncated miR-17 cluster (miR17-19b cluster, highly expressing all miRNAs but miR-92) caused the mice to develop leukemia much more rapidly (average of 51 days compared to 3-6 months in control animals) and with a penetrance of 100% compared to 30% in the control animals. In addition, the lymphoma derived from Em-myc/miR-17-19b mice showed a high mitotic index without extensive apoptosis. In contrast, lymphoma derived from control animals lacking the miRNA cluster (Em-myc/MSCV), showed a high degree of apoptosis. These results indicate that Em-myc and miR-17-19b cooperate to give rise to a highly malignant lymphoma capable of evading the apoptotic response that is normally induced in response to inappropriate proliferation.
Cooperating oncogenes usually function in separate biological processes. It is thus rather surprising that expression of the miR-17 cluster has been reported to be under the direct control of c-Myc; O'Donnell et al. (2005) found that increased expression of c-Myc lead to increased expression of the miR-17 cluster. In addition, chromatin immunoprecipitation experiments showed that c-Myc binds directly to the miR-17 cluster. By computational searches, the authors identified E2F1 as a potential target of two miRNAs within that cluster. Interestingly, E2F1 is also a transcriptional target of c-Myc. E2F1 promotes DNA replication and cell cycle progression, and induces c-Myc expression in a positive feedback loop (Leone et al., 1997; Fernandez et al., 2003; Matsumura et al., 2003; Bracken et al., 2004) . The authors provide experimental evidence that these two miRNAs negatively regulate E2F1 and propose a mechanism through which c-Myc simultaneously activates E2F1 transcription and miR-17 cluster expression, which in turn limits E2F1 translation, allowing for a tightly regulated proliferative signal. As excessive E2F signaling can lead to apoptosis (Trimarchi and Lees, 2002) , the authors suggest that diminishing its expression might drive the proliferative signal without inducing apoptosis. However, this clearly cannot be the sole, and likely not even the major mechanism of cooperation with c-Myc. Of course, the other miRNAs within the cluster might regulate other oncogenes or tumor suppressors whose downregulation, together with that of E2F1, could contribute to malignancy. For example, the tumor suppressor PTEN (phosphatase and tensin homolog deleted on chromosome ten) is a suggested target of miR-19, a member of the miR-17 cluster (Lewis et al., 2003; Hammond, 2006) .
Further complicating the picture, LOH of 13q31-32 (and therefore of the miR-17 cluster) is known to occur in several types of tumors (Lin et al., 1999) . Whether the miR-17 cluster or a nearby, still unidentified tumor suppressor is the target of these LOH events remains to be determined. However, given the impressive ability of miRNAs to show different, and on occasion even opposite activities depending on the cell type or the experimental conditions, it might well be that the miR-17 cluster can act either as a tumor suppressor or as an oncogene, depending on the circumstances.
A virus-encoded miRNA with an antiapoptotic function The latency-associated transcript (LAT) of the herpes simplex virus-1 (HSV-1) has been known for some time to maintain latent infection of HSV-1 by promoting the survival of infected neurons (Perng et al., 2000) . However, no protein product has been identified within the LAT gene and therefore the mechanism by which LAT confers resistance to apoptosis has not been miRNAs and apoptosis M Jovanovic and MO Hengartner known. In a recent paper, Gupta et al. (2006) reported that LAT codes for a miRNA that is responsible for the observed antiapoptotic activity of LAT in infected cells. Consequently, the authors named this miRNA as miR-LAT. Deletion of miR-LAT resulted in greater apoptosis in infected cells upon stress. Conversely, miR-LAT itself was able to suppress apoptosis significantly in stressed cells. In order to gain insight into the mechanism how miR-LAT is able to suppress apoptosis, the authors searched the human genome for possible target genes by computational analysis. Using the miRanda algorithm (John et al., 2004) , the authors could identify the transforming growth factor-b1 (TGF-b) and SMAD3 as potential targets of miR-LAT. Both factors participate in TGF-b signaling (Feng and Derynck, 2005) and have important roles in diverse cellular processes. Moreover, it is known that TGF-b is a potent inhibitor of cell growth and an inducer of apoptosis (Schuster and Krieglstein, 2002) . These facts encouraged Gupta et al. (2006) to further investigate the interaction of miR-LAT with TGF-b and SMAD-3. First of all, they could show that the mRNA levels as well as the protein levels of these two genes were lower in LAT-expressing cells. Moreover, the activity of a luciferase reporter gene fused to the 3 0 UTR of either TGF-b or SMAD-3 was significantly reduced upon cotransfection with LAT or a double-stranded RNA oligonucleotide encoding miR-LAT itself. Thus, the authors concluded that the miR-LAT miRNA helps the virus to establish latency by allowing avoidance of TGF-b-induced apoptosis following infection.
Of course, it makes sense for viruses to use one of the smallest type of regulatory molecules known, miRNAs, to their advantage, as the size of their genome is often under evolutionary pressure. What is more surprising is that some viruses also express proteins that antagonize the miRNA and/or RNAi machinery of the infected cell. One major function of this class of viral proteins is likely to restrict RNAi-mediated anti-viral responses of the host cell (Lecellier et al., 2005; Sullivan and Ganem, 2005; Schutz and Sarnow, 2006) . However, it is tempting to speculate that these kinds of proteins might, through their interference of miRNA expression, also promote cancer development; as mentioned above, in most types of cancer a majority of the miRNAs is downregulated (Lu et al., 2005) , which could help the cells dedifferentiate and regain the potential to proliferate. Although intellectually attractive, this hypothesis still needs experimental testing.
Conclusive remarks
The miRNA field is currently one of the fastest growing fields in molecular biology. The attention this field is receiving is well justified, as it elucidates a fascinating layer of cell regulation not appreciated until recently. Moreover, the involvement of miRNAs in the regulation of several biological processes and in important diseases such as cancer underlines their importance. In this review, we have summarized the involvement of miRNAs in apoptosis and in doing so we have encountered some of the many questions that still need to be answered in order to fully understand their function. Where and when are miRNAs expressed? Which transcription factors regulate their expression? What are their targets? And most importantly, how does the list of targets change under different conditions? Until we can answer these questions, our view of miRNA function will remain somewhat blurry. However, as we all know, things are often more attractive and interesting when still slightly veiled.
